Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Synthesis and secretion of albumin in rats during treatment with a carcinogenic dose of N-2-acetylaminofluorene

Abstract

The chronic administration of N-2-acetylaminofluorene (N-2-AAF) to rats causes a loss of hepatic cytoplasmic RNA, particularly from the endoplasmic-membrane fractions. At the end of the complete carcinogenic dose, the level of amino-acid incorporation into proalbumin is normal, despite the loss of 35% of membrane-bound RNA. The secretion of albumin, however, is inhibited. This inhibition of secretion is apparently the result of a change in membrane flow and differentiation, transfer of nascent protein from smooth-surfaced vesicles to the Golgi apparatus is blocked. The significance of these findings is discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harson, M., Williams, D. Synthesis and secretion of albumin in rats during treatment with a carcinogenic dose of N-2-acetylaminofluorene. Br J Cancer 40, 791–797 (1979). https://doi.org/10.1038/bjc.1979.262

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1979.262

Search

Quick links